# Peter Rossing

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/peter-rossing/

## Facts

| Field | Value |
| --- | --- |
| Citations | 80,750 |
| Field | Diabetes Treatment and Management |
| h-index | 123 |
| i10-index | 627 |
| Last Known Institution | University of Copenhagen |
| OpenAlex ID | https://openalex.org/A5085592050 |
| ORCID iD | 0000-0002-1531-4294 |
| Works | 1,396 |

## Researcher papers

Showing 12 of 80.

- [Dapagliflozin in Patients with Chronic Kidney Disease](https://scholariq.org/papers/dapagliflozin-in-patients-with-chronic-kidney-disease/)
- [2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD](https://scholariq.org/papers/2019-esc-guidelines-on-diabetes-pre-diabetes-and-cardiovascular-diseases/)
- [Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)](https://scholariq.org/papers/management-of-hyperglycemia-in-type-2-diabetes-2018-a-consensus-report-by-the/)
- [Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes](https://scholariq.org/papers/effect-of-finerenone-on-chronic-kidney-disease-outcomes-in-type-2-diabetes/)
- [Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)](https://scholariq.org/papers/management-of-hyperglycemia-in-type-2-diabetes-2022-a-consensus-report-by-the/)
- [Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes](https://scholariq.org/papers/effects-of-semaglutide-on-chronic-kidney-disease-in-patients-with-type-2/)
- [Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)](https://scholariq.org/papers/management-of-hyperglycaemia-in-type-2-diabetes-2018-a-consensus-report-by-the/)
- [Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis](https://scholariq.org/papers/associations-of-kidney-disease-measures-with-mortality-and-end-stage-renal/)
- [KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease](https://scholariq.org/papers/kdigo-2022-clinical-practice-guideline-for-diabetes-management-in-chronic-kidney/)
- [Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis](https://scholariq.org/papers/cardiovascular-and-kidney-outcomes-with-finerenone-in-patients-with-type-2/)
- [Diabetic kidney disease](https://scholariq.org/papers/diabetic-kidney-disease/)
- [Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)](https://scholariq.org/papers/management-of-hyperglycaemia-in-type-2-diabetes-2022-a-consensus-report-by-the/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)

## Researcher university

- [University of Copenhagen](https://scholariq.org/institutions/university-of-copenhagen/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.